May 18, 1993
Biopool International Inc., which makes test kits for diagnosing blood disorders, reported a 36% drop in earnings in the first quarter. The Ventura company said its profit in the three months ended March 31 was $78,349, down from net income of $121,496 a year before. Its revenue fell 13%, to $1.03 million from $1.18 million. Biopool said the results reflected lower sales from its Swedish subsidiary because of the decline in the value of the Swedish currency compared to the dollar.
May 11, 1993 |
Biopool International Inc. of Ventura has received Japanese government approval for the use of Biopool's TintElize Lp(a) test kit for diagnosing heart disease risks. The action opens the largest potential market thus far for the kit, which measures Lipoprotein(a), a form of blood cholesterol that is a major risk factor for coronary artery disease and other heart-related problems, said Michael D. Bick, Biopool's chief executive officer.
March 23, 1993 |
Two Ventura County firms are planning to raise cash through stock sales--in one case, to purchase a holding company that was set up in an unsuccessful takeover attempt. California Amplifier Inc., a Camarillo producer of equipment used in distributing TV signals by microwave, is seeking Securities and Exchange Commission approval for a proposed offering of 1 million common shares.
March 16, 1993
Biopool International Inc., a Ventura maker of blood diagnostic kits, reported profits for the fourth quarter and all of 1992, in contrast with year-earlier losses. Biopool earned $188,292 in the three months that ended Dec. 31, while its sales rose 26% to $956,898. A year earlier, it lost $202,470 on $762,160 in sales. The company said its full-year profit totaled $626,670, compared to a loss of $351,652 in 1991, and its annual sales jumped 83%, to $4.87 million from $2.66 million.
February 23, 1993
Biopool International, which makes medical testing equipment, plans to distribute products from its MeDiTech subsidiary in China and Hong Kong, the company said. Ventura-based Biopool said the distribution will be handled by Letrich Industries, which is headquartered in Hong Kong.
January 26, 1993 |
Biopool International Inc., a Ventura-based producer of test kits for diagnosing blood, vascular and other disorders, has been granted two new patents and has nearly doubled its sales in the past year, said Michael D. Bick, chief executive officer. One of the patents is for an improved method of collecting samples used in testing blood clotting and dissolving, Bick said.
November 10, 1992
Biopool International Inc., a Ventura marketer of medical test kits sold to hospitals and laboratories, posted a third-quarter profit of $145,169 compared with a year-earlier loss of $101,444. The profit in the quarter ended Sept. 30 came as Biopool's sales more than doubled, to $1.26 million from $549,759 a year earlier. The company said the gains reflected wider distribution of its equipment and new-product introductions.
November 3, 1992 |
Biopool International Inc., a Ventura firm that produces medical diagnostic kits, has received approval from the Food and Drug Administration to market two new kits. The first, called the Minutex D-Dimer, tests patients for deep-vein thrombosis or blood clots, said Michael D. Bick, Biopool's chief executive. He said the kit is less costly and takes less time than other tests now being used.
May 19, 1992
Biopool International Inc., a Ventura provider of medical diagnostic test kits, said it earned $121,496 in the first quarter, its first operating profit since the company's founding in 1987. The profit in the quarter that ended March 31 compared with a year-earlier loss of $48,301, and came on a 68% jump in its sales, to $1.18 million from $704,200.